Kinetic analysis of the 4-methylideneimidazole-5-one-containing tyrosine aminomutase in enediyne antitumor antibiotic C-1027 biosynthesis

被引:62
作者
Christenson, SD
Wu, WM
Spies, MA
Shen, B
Toney, MD
机构
[1] Univ Calif Davis, Dept Chem, Davis, CA 95616 USA
[2] San Francisco State Univ, Dept Chem & Biochem, San Francisco, CA 94132 USA
[3] Univ Wisconsin, Div Pharmaceut Sci, Madison, WI 53705 USA
[4] Univ Wisconsin, Dept Chem, Madison, WI 53705 USA
关键词
D O I
10.1021/bi035223r
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The enediyne antitumor antibiotic C-1027 contains an unusual (S)-3-chloro-4,5-dihydroxy-beta-phenylalanine moiety, which requires an aminomutase for its biosynthesis. Previously, we established that SgcC4 is an aminomutase that catalyzes the conversion of L-tyrosine to (S)-beta-tyrosine and employs 4-methylideneimidazole-5-one (MIO) at its active site [Christenson, S. D., Liu, W., Toney, M. D., and Shen, B. (2003) J. Am. Chem. Soc. 125, 6062-6063]. Here, we present a thorough analysis of the properties of SgcC4. L-Tyrosine is the best substrate among those tested and most likely serves as the in vivo precursor for the (S)-3-chloro-4,5-dihydroxy-beta-phenylalanine moiety. The presence of MIO in the active site is supported by several lines of evidence. (1) Addition of ATP or divalent metal ions has no effect on its aminomutase activity. (2) SgcC4 has optimal activity at pH similar to8.8, similar to the pH optima of MIO-dependent ammonia lyases. (3) SgcC4 is strongly inhibited by sodium borohydride and potassium cyanide, but preincubation with L-tyrosine or 4-hydroxycinnamate largely prevents this inhibition. (4) The difference spectrum between SgcC4 and its S153A mutant shows a positive peak at similar to310 nm, indicative of MIO. (5) The S153A mutation lowers k(cat)/K-m 640-fold. The SgcC4-catalyzed conversion of L-tyrosine to (S)-beta-tyrosine proceeds via 4-hydroxycinnamate as an intermediate. The latter also acts as a competitive inhibitor with respect to L-tyrosine and serves as an alternative substrate for the production of beta-tyrosine in the presence of an amino source. A full time course for the SgcC4-catalyzed interconversion between L-tyrosine, beta-tyrosine, and 4-hydroxycinnamate was measured and analyzed to provide estimates for the rate constants in a minimal mechanism. SgcC4 also exhibits a beta-tyrosine racemase activity, but alpha-tyrosine racemase activity was not detected.
引用
收藏
页码:12708 / 12718
页数:11
相关论文
共 50 条
  • [21] Characterization of a bacterial tyrosine ammonia lyase, a biosynthetic enzyme for the photoactive yellow protein
    Kyndt, JA
    Meyer, TE
    Cusanovich, MA
    Van Beeumen, JJ
    [J]. FEBS LETTERS, 2002, 512 (1-3) : 240 - 244
  • [22] Formation of the Michaelis complex without involvement of the prosthetic group dehydroalanine of histidine ammonialyase
    Langer, B
    Starck, J
    Langer, M
    Retey, J
    [J]. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 1997, 7 (08) : 1077 - 1082
  • [23] Identification of essential amino acids in phenylalanine ammonia-lyase by site-directed mutagenesis
    Langer, B
    Rother, D
    Retey, J
    [J]. BIOCHEMISTRY, 1997, 36 (36) : 10867 - 10871
  • [24] Langer B, 2001, ADV PROTEIN CHEM, V58, P175
  • [25] THE ROLE OF DEHYDROALANINE IN CATALYSIS BY HISTIDINE AMMONIA-LYASE
    LANGER, M
    PAULING, A
    RETEY, J
    [J]. ANGEWANDTE CHEMIE-INTERNATIONAL EDITION IN ENGLISH, 1995, 34 (13-14): : 1464 - 1465
  • [26] IDENTIFICATION OF SERINE-143 AS THE MOST LIKELY PRECURSOR OF DEHYDROALANINE IN THE ACTIVE-SITE OF HISTIDINE AMMONIA-LYASE - A STUDY OF THE OVEREXPRESSED ENZYME BY SITE-DIRECTED MUTAGENESIS
    LANGER, M
    RECK, G
    REED, J
    RETEY, J
    [J]. BIOCHEMISTRY, 1994, 33 (21) : 6462 - 6467
  • [27] HISTIDINE AMMONIA-LYASE MUTANT-S143C IS POSTTRANSLATIONALLY CONVERTED INTO FULLY ACTIVE WILD-TYPE ENZYME - EVIDENCE FOR SERINE-143 TO BE THE PRECURSOR OF ACTIVE-SITE DEHYDROALANINE
    LANGER, M
    LIEBER, A
    RETEY, J
    [J]. BIOCHEMISTRY, 1994, 33 (47) : 14034 - 14038
  • [28] Genes for production of the enediyne antitumor antibiotic C-1027 in Streptomyces globisporus are clustered with the cagA gene that encodes the C-1027 apoprotein
    Liu, W
    Shen, B
    [J]. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2000, 44 (02) : 382 - 392
  • [29] Biosynthesis of the enediyne antitumor antibiotic C-1027
    Liu, W
    Christenson, SD
    Standage, S
    Shen, B
    [J]. SCIENCE, 2002, 297 (5584) : 1170 - 1173
  • [30] MORELY CGD, 1972, BIOCHEMISTRY-US, V11, P600